Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Total Non-Current Liabilities (2018 - 2025)

Quantum Biopharma's Total Non-Current Liabilities history spans 8 years, with the latest figure at $6.1 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities changed N/A to $6.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.1 million, a N/A change, with the full-year FY2025 number at $6.1 million, changed N/A from a year prior.
  • Total Non-Current Liabilities hit $6.1 million in Q4 2025 for Quantum Biopharma, down from $6.6 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for QNTM hit a ceiling of $7.5 million in Q1 2025 and a floor of -$2.0 million in Q1 2021.
  • Historically, Total Non-Current Liabilities has averaged $1.8 million across 5 years, with a median of -$122351.0 in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: plummeted 98.97% in 2022 and later surged 4223.27% in 2024.
  • Tracing QNTM's Total Non-Current Liabilities over 5 years: stood at $3.7 million in 2021, then plummeted by 98.97% to $38004.0 in 2022, then tumbled by 443.08% to -$130383.0 in 2023, then surged by 2923.19% to $3.7 million in 2024, then skyrocketed by 64.58% to $6.1 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for QNTM at $6.1 million in Q4 2025, $6.6 million in Q3 2025, and $5.5 million in Q2 2025.